Qube Research & Technologies (QRT)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,600
Closed -$212K 3652
2024
Q4
$212K Hold
1,600
﹤0.01% 2825
2024
Q3
$233K Hold
1,600
﹤0.01% 2524
2024
Q2
$220K Sell
1,600
-600
-27% -$80.1K ﹤0.01% 2398
2024
Q1
$302K Buy
+2,200
New +$300K ﹤0.01% 2810

Other funds holding IBB

Qube Research & Technologies (QRT)'s IBB Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its iShares Biotechnology ETF (IBB) stake by 500% in Q1 2026, buying an estimated $997K and bringing the position to 6,997 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2418.

Qube Research & Technologies (QRT) first reported a position in IBB in Q2 2020 and has held it in 15 quarters since. The position peaked at $63.7M in Q3 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Qube Research & Technologies (QRT) held 6,997 shares of iShares Biotechnology ETF worth $1.18M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 5,831 iShares Biotechnology ETF shares in Q1 2026, an estimated $997K.
  • iShares Biotechnology ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2418 holding.
  • Qube Research & Technologies (QRT) first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 15 quarters since.
  • Qube Research & Technologies (QRT)'s iShares Biotechnology ETF position peaked at $63.7M in Q3 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.